%0 Journal Article
%T Shadow cost of oral corticosteroids-related adverse events: A£¿pharmacoeconomic evaluation applied to real-life data from£¿the£¿Severe£¿Asthma Network in Italy (SANI) registry
%A Caterina Bucca
%A Chiara Martinotti
%A Enrico Heffler
%A Francesco Blasi
%A Giacomo Matteo Bruno
%A Gianenrico Senna
%A Giorgio Lorenzo Colombo
%A Giorgio Walter Canonica
%A Giovanni Passalaqua
%A Girolamo Pelaia
%A Nunzio Crimi
%A Pierluigi Paggiaro
%A SANI Network
%A Sergio Di Matteo
%J Archive of "The World Allergy Organization Journal".
%D 2019
%R 10.1016/j.waojou.2018.12.001
%X Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this study is to create a pharmacoeconomic model to predict the costs of corticosteroid-related adverse events in severe asthmatics and applying it to the first published epidemiologic data from the Severe Asthma Network in Italy (SANI) registry
%K Severe asthma
%K Oral corticosteroids
%K Adverse events
%K Pharmacoeconomy
%K Costs
%K Diabetes
%K Glaucoma
%K Obesity
%K Bone fracture
%K Chronic kidney disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439414/